Umeå-based Lipigon Pharmaceuticals is celebrating the signing of a development and license agreement for its clinical-stage drug candidate Lipisense® with Leaderna Therapeutics worth an estimated USD 91 million.
Umeå University has in collaboration with HiloProbe AB completed the first part of a new clinical study of its ColoNode biomarker test, which provides further important evidence for the product ColoNode's benefits and usefulness in colon cancer.
Umeå Biotech Incubator has been granted SEK 14 million for the ERDF project "Life science city", which will further develop the life science industry in the region.
He has been a vital part of Umeå Biotech Incubator (UBI) since its inception in 2003. But now, after 42 years of service in the biotech industry, it is time for respected research engineer Assar Bäckman to retire. “My work has been hugely varied, and over the years I have learned a great deal. I usually have an emergency solution to most things if needed”, says Assar.
Experienced business coach Peter Jacobsson will now lead Umeå Biotech Incubator until a permanent replacement is appointed.
The Umeå Biotech Incubator-backed ‘Shades of Green’ project, developed by Boreal Orchards, has created a moss that can be used on buildings, infrastructure and for the regeneration of nature. Now founder Daniel Pacurar is collaborating on a new development project with RISE Processum AB and Ecohelix to maximize moss establishment with the help of by-products from the paper pulp industry.
Jennie Ekbeck, CEO of Umeå Biotech Incubator, has been awarded an honorary doctorate for 2023 at the Faculty of Science and Technology at Umeå University. “I want research to benefit people, that is my driving force,” she says.
Umeå Biotech Incubator (UBI) has won the Regio Stars Västerbotten 2023 award for its ‘Life Science Motorn 2.0’ regional fund project in the category "A region with localized sustainable business development".
QureTech Bio AB (QTB), a pharmaceutical development company originating from Umeå University, proudly announces the appointment of three new board members at its Annual General Meeting held on May 25, 2023. This strategic move is aimed at further enhancing QTB's drug and business development.
The newly appointed board members are:
Yijing Sun Hultgren
Yijing has over a decade of experience
Life science consulting company Orderly People has announced it will base one of its consultants in Umeå after the summer. “There is a vibrant life science industry in Umeå which we want to be a part of”, says Orderly People's founder and co-owner, Maria Jansson.
Umeå-based HiloProbe AB has entered a partnership with the major international company Biocartis Group NV. This is a strategically important step for HiloProbe in its aim to reach out globally with its colorectal cancer test product, ColoNode®.
Umeå-based biopharmaceutical company Omnio AB, which is currently awaiting efficacy data from preclinical wound studies using recombinant plasminogen, has recently appointed an internationally experienced board of directors charged with taking the company forward.